Avid Bioservices, Inc. operates as a pharmaceutical company. The Company focuses on development and manufacturing of biopharmaceutical products derived from mammalian cell culture, as well as provides clinical and commercial manufacturing services. Avid Bioservices serves customers in the United States.

Quarterly Report (Form 10-Q | Period ending 2024-01-31)

Quarterly Report (Amendment) (Form 10-Q/A | Period ending 2023-10-31)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Avid Bioservices (CDMO US)

Quarterly Report (Form 10-Q | Period ending 2024-01-31)

Quarterly Report (Amendment) (Form 10-Q/A | Period ending 2023-10-31)

Quarterly Report (Amendment) (Form 10-Q/A | Period ending 2023-07-31)

Annual Report (Amendment) (Form 10-K/A | Period ending 2023-04-30)

Current Report (Form 8-K | Period ending 2024-03-19)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)